Damascenine induced hepatotoxicity and nephrotoxicity in mice and in vitro assessed human erythrocyte toxicity
References
- Bechan S, Devendra KR, Prashant KR, Rizvi SI, Geeta W. (2010). Determination of erythrocyte fragility as a marker of pesticide-induced membrane oxidative damage.: 123–128.
- Bekemeier H, Leuschner G, Schmollack W. (1967). Antipyretic, antiedematous and analgetic effects of damascenine in comparison with acetylsalicylic acid and phenylbutazone.(1): 199–211.
- Bouguezza Y, Bribi N, Tacherfiout M, Amara S, Khettal B. (2013). Acute and sub-chronic toxicity study ofmethanolic seed extract in mice.(2): 413–419.
- Döpke W, Fritsch G. (1970). Der Alkaloidgehalt vonL.: 69–70.
- Edward AL, Celia JR. (1998). Xenobiotic Metabolizing Enzymes of the Kidney.(1): 18–25.
- Emerson FS, Shadara AC, Devi PU. (1993). Toxic effects of crude extract of Plumbago rosea (Rokta chitraka).: 79–84.
- Ewins AJ. (1912). LXII. –The constitution and synthesis of damascenine, the alkaloid of.: 544–552.
- Fico G, Tomè F. (1998). Akaloids content in the ripening seeds of.Sci(Suppl 1): S79.
- Fico G, Panizzi L, Flamini G, Braca A, Morelli I, Tomè F, Cioni PL. (2004). Biological screening of Nigella damascena for antimicrobial and molluscicidal activities.(6): 468–470.
- Kew MC. (2000). Serum aminotransferase concentration as evidence of hepatocellular damage.(9204): 591–2.
- Liangyou R. (2014). Energy metabolism in the liver.(1): 177–197.
- Mohan LV, Mothes K, Engelbrecht L, Schroter HB. (1965). Biosynthesis of damascenine in.: 1421–1428.
- Necyk C, Tsuyuki RT, Boon H, Foster BC,(2014). Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality.(3): e003431.
- OECD, Test guideline 407. (2008). Repeated dose oral toxicity test method. In:. Section 4-Health Effects, Paris, France.
- Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. (2008). The current state of serum biomarkers of hepatotoxicity.: 194–205.
- Sener G, Sehirli AO, Altunbas H.Z, Ersoy Y, Paskaloglu KA, Ayanoglu-Dugler G. (2002). Melatonin protects against gentamicin induced nephrotoxicity in rats.: 231–236.
- Sirwal IA, Banday KA, Reshi AR, Bhat MA, Wani MM. (2004). Estimation of Glomerular Filteration Rate (GFR).: 121–123.
- Stillman AE. (1990). Jaundice, in: The History, Physical, and Laboratory Examinations () pp. 448–456.
- Udem SC, Obidoa O, Asuzu IU. (2009). Acute and chronic toxicity studies ofDC stem bark extract in mice.: 275–282.
- Valdiguié P. (2000). Constituant azotés non protéique, in() pp. 267, Cedex.
- Vohra S, Cvijovic K, Boon H, Foster BC(2012). Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies.(9): e45196.
- Wyss M, Kaddurah-Daouk R. (2000). Creatine and creatinine metabolism.(3): 1107–213.
- Xian-guo HE, Ursula M. (1994). Antifungal compound from.: 173–17.
Language: English
Page range: 118 - 124
Submitted on: Jan 16, 2015
Accepted on: Sep 17, 2015
Published on: Mar 7, 2016
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2016 Yacine Bouguezza, Bachra Khettal, Lydia Tir, Souad Boudrioua, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.